![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
.jpg)
Congressional commission urges $15B, more action to maintain US biotech advantage over China
A U.S. congressional commission has made the case for “swift action” to maintain the nation’s role as a biotech superpower while warning the sector is “dangerously close to falling behind China.”
A U.S. congressional commission has made the case for “swift action” to maintain the nation’s role as a biotech superpower while warning the sector is “dangerously close to falling behind China.”
